Skip to main content
Clinical Trials/NCT01081509
NCT01081509
Completed
Not Applicable

Survey and Follow-up of the Treatment Adherence and Medication Habits of Early Breast Cancer Patients on Adjuvant Hormonal Therapy With the Aromatase Inhibitor Arimidex

AstraZeneca1 site in 1 country1,077 target enrollmentMarch 2010
ConditionsBreast Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
AstraZeneca
Enrollment
1077
Locations
1
Primary Endpoint
Percent of patients remaining adherent to therapy with Arimidex
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

The aim of this study is to assess the patient's perception about and willingness to take his or her medication and the influencing factors interfering with taking medication.

Registry
clinicaltrials.gov
Start Date
March 2010
End Date
October 2011
Last Updated
14 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Early breast cancer
  • Post menopausal
  • Adjuvant hormonal Arimidex therapy

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Percent of patients remaining adherent to therapy with Arimidex

Time Frame: Every 3 months

Secondary Outcomes

  • Questionnaire for factors influencing adherence(Every 3 months)

Study Sites (1)

Loading locations...

Similar Trials